Aralez Announces Departure of CFO

Pharmaceutical Investing

Aralez Pharmaceuticals announced the departure of Scott J. Charles, its chief financial officer, effective immediately.

Aralez Pharmaceuticals (NASDAQ: ARLZ; TSX:ARZ) announced the departure of Scott J. Charles, its chief financial officer, effective immediately.
As quoted in the press release:

Michael Kaseta will assume the position of Interim Chief Financial Officer (“CFO”) along with his current duties as Corporate Controller. Mr. Kaseta has served as Corporate Controller since 2016 and brings a breadth of experience in all aspects of the Company’s financial operations. Prior to joining Aralez, Mr. Kaseta served as CFO of Sanofi North America, Global Services.

“The Board and I want to wish Scott the best in his future endeavors,” said Adrian Adams, Chief Executive Officer of Aralez. “We have full confidence in Mike’s ability to lead our finance operations, and we expect a seamless transition. As outlined in our recent third quarter press release, we are now positioning the Company for the next phase of growth as illustrated in our updated 2017 financial guidance and preliminary 2018 outlook. We are confident that we are on the pathway to achieve sustained profitability and growth as we execute on our goals to deliver shareholder value.”

Click here to read the full press release.


The Conversation (0)